Versant Voyageurs
Startup rounds since 2018 with a Versant Voyageurs investor on the board, and the firm's own fund filings.
Raises
21
since 2018
Unannounced
0
no announcement found, of those filed since 2025
Funds
4
fund filings under the firm's name
Rounds
- Lycia Therapeutics, Inc.$75M
- Nexo Therapeutics, Inc.$60M
- Pep2Tango Therapeutics, Inc.$16.7M
- 858 Therapeutics, Inc.$25.2M
- Lycia Therapeutics, Inc.$107M
- Jnana Therapeutics Inc.$107M
- Lenz Therapeutics, Inc.$83.5M
- Lenz Therapeutics, Inc.$49M
- March Therapeutics, Inc.$20.3M
- Lycia Therapeutics, Inc.$70.1M
- Jnana Therapeutics Inc.$50M
- 858 Therapeutics, Inc.$20M
- Graphite Bio, Inc.$151M
- Century Therapeutics, Inc.Undisclosed
- Jengu Therapeutics, Inc.$5M
- Lycia Therapeutics, Inc.$25.4M
- 858 Therapeutics, Inc.$20.1M
- Oyster Point Pharma, Inc.$85M
- VenatoRx Pharmaceuticals, Inc.$27.1M
- Mistral Therapeutics, Inc.$25.9M
- Pandion Therapeutics, Inc.$21.6M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 2 | 0 |
| 2024 | 4 | — |
| 2023 | 1 | — |
| 2022 | 2 | — |
| 2021 | 5 | — |
| 2020 | 3 | — |
| 2019 | 1 | — |
| 2018 | 3 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Versant Voyageurs III, L.P. | 7 Apr 2023 | $300M | $300M |
| Versant Voyageurs II, L.P. | 15 Apr 2021 | $140M | $140M |
| Versant Voyageurs I, L.P. | 13 Aug 2019 | $102M | $102M |
| Versant Voyageurs I Feeder, L.P. | 25 Apr 2018 | $20M | $20M |
Listed because a Versant Voyageurs fund's filing names a director of each company. A name match is not a verified identity.